Within the BRCA1 mutation-positive group, homozygous 72Pro carriers had the youngest ages of diagnoses of breast cancer than that of the homozygous 72Arg (p = 0.31) and heterozygous (p = 0.36) carriers, although these observations were not significant. The gene discussed is BRCA1; the disease is breast cancer.